Adrenergic receptor gene variation and selective norepinephrine reuptake inhibitors

American Journal of Psychiatry

Volumn 170, Issue 4, 2013, Pages 446-447

  Gibbs, Ayana A ^a   Somal, Sirpreet K ^a   Chan, Ki Fung D ^a   Bautista, Carla E ^a   Mowlem, Florence D ^a   Naudts, Kris H ^a   Van Heeringen, Kees ^a   Duka, Theodora ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; REBOXETINE; ADRENERGIC RECEPTOR AFFECTING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; MORPHOLINE DERIVATIVE;

ADRENERGIC RECEPTOR GENE; ANXIETY; CLINICAL EFFECTIVENESS; DEPRESSION; DIZZINESS; DRUG APPROVAL; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; GENE; GENE DELETION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HEART PALPITATION; HUMAN; IRRITABILITY; LETTER; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT; SINGLE DRUG DOSE; SWEATING; TIME TO MAXIMUM PLASMA CONCENTRATION; XEROSTOMIA; ADOLESCENT; ADULT; CARDIOVASCULAR FUNCTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; GENETICS; MALE; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; HUMANS; MALE; MORPHOLINES; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 84883062635     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2013.12111454     Document Type: Letter

References (6)

1. Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kaiser T, Kerekes MF, Gerken M, Wieseler B: Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010; 341:c4737
2. Philipp M, Brede M, Hein L: Physiological significance of a(2)- adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol 2002; 283: R287-R295
3. Small KM, Brown KM, Forbes SL, Liggett SB: Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 2001; 276: 4917-4922
4. de Quervain DJF, Kolassa IT, Ertl V, Onyut PL, Neuner F, Elbert T, Papassotiropoulos A: A deletion variant of the a2b-adrenoceptor is related to emotional memory in Europeans and Africans. Nat Neurosci 2007; 10: 1137-1139
5. Naudts KH, Azevedo RT, David AS, van Heeringen K, Gibbs AA: Epistasis between 5-HTTLPR and ADRA2B polymorphisms influences attentional bias for emotional information in healthy volunteers. Int J Neuropsychopharmacol 2012; 15: 1027-1036
6. Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, Brockmöller J: Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 2004; 9: 442-473